5
Participants
Start Date
November 9, 2021
Primary Completion Date
May 31, 2022
Study Completion Date
May 31, 2022
Spesolimab
Spesolimab
Placebo
Placebo
Washington University School of Medicine, St Louis
Heritage Medical Research Clinic, Calgary
Kitasato Institute Hospital, Tokyo, Minato-ku
Sahlgrenska Universitetssjukhuset, Mölndal, Mölndal
Lead Sponsor
Boehringer Ingelheim
INDUSTRY